162 related articles for article (PubMed ID: 15459946)
21. Paracellular drug transport across intestinal epithelia: influence of charge and induced water flux.
Karlsson J; Ungell A; Gråsjö J; Artursson P
Eur J Pharm Sci; 1999 Oct; 9(1):47-56. PubMed ID: 10493996
[TBL] [Abstract][Full Text] [Related]
22. Quasi-equilibrium analysis of the ion-pair mediated membrane transport of low-permeability drugs.
Miller JM; Dahan A; Gupta D; Varghese S; Amidon GL
J Control Release; 2009 Jul; 137(1):31-7. PubMed ID: 19264104
[TBL] [Abstract][Full Text] [Related]
23. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
Akamatsu M; Fujikawa M; Nakao K; Shimizu R
Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
[TBL] [Abstract][Full Text] [Related]
24. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
25. In situ artificial membrane permeation assay under hydrodynamic control: correlation between drug in vitro permeability and fraction absorbed in humans.
Velický M; Tam KY; Dryfe RA
Eur J Pharm Sci; 2011 Oct; 44(3):299-309. PubMed ID: 21864679
[TBL] [Abstract][Full Text] [Related]
26. Transport evaluation of salicylic acid and structurally related compounds across Caco-2 cell monolayers and artificial PAMPA membranes.
Koljonen M; Rousu K; Cierny J; Kaukonen AM; Hirvonen J
Eur J Pharm Biopharm; 2008 Oct; 70(2):531-8. PubMed ID: 18582575
[TBL] [Abstract][Full Text] [Related]
27. Quantitative structure-permeability relationships at various pH values for acidic and basic drugs and drug-like compounds.
Oja M; Maran U
SAR QSAR Environ Res; 2015; 26(7-9):701-19. PubMed ID: 26383235
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
[TBL] [Abstract][Full Text] [Related]
29. New biomimetic barrier Permeapad™ for efficient investigation of passive permeability of drugs.
di Cagno M; Bibi HA; Bauer-Brandl A
Eur J Pharm Sci; 2015 Jun; 73():29-34. PubMed ID: 25840123
[TBL] [Abstract][Full Text] [Related]
30. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability.
Fujikawa M; Ano R; Nakao K; Shimizu R; Akamatsu M
Bioorg Med Chem; 2005 Aug; 13(15):4721-32. PubMed ID: 15936203
[TBL] [Abstract][Full Text] [Related]
31. The effect of hyperosmosis on paracellular permeability in Caco-2 cell monolayers.
Inokuchi H; Takei T; Aikawa K; Shimizu M
Biosci Biotechnol Biochem; 2009 Feb; 73(2):328-34. PubMed ID: 19202294
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the artificial membrane permeability of drugs by digital simulation.
Nakamura M; Osakai T
Eur J Pharm Sci; 2016 Aug; 91():154-61. PubMed ID: 27334569
[TBL] [Abstract][Full Text] [Related]
33. Membrane permeability in the gastrointestinal tract: the interplay between microclimate pH and transporters.
Kristl A
Chem Biodivers; 2009 Nov; 6(11):1923-32. PubMed ID: 19937830
[TBL] [Abstract][Full Text] [Related]
34. pH-permeability profiles for drug substances: Experimental detection, comparison with human intestinal absorption and modelling.
Oja M; Maran U
Eur J Pharm Sci; 2018 Oct; 123():429-440. PubMed ID: 30100533
[TBL] [Abstract][Full Text] [Related]
35. Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate: assessment of molecular weight dependence and demonstration of transport routes.
Lindmark T; Schipper N; Lazorová L; de Boer AG; Artursson P
J Drug Target; 1998; 5(3):215-23. PubMed ID: 9606011
[TBL] [Abstract][Full Text] [Related]
36. Epithelial transport of drugs in cell culture. II: Effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells.
Artursson P; Magnusson C
J Pharm Sci; 1990 Jul; 79(7):595-600. PubMed ID: 2118955
[TBL] [Abstract][Full Text] [Related]
37. Fluorescein transport properties across artificial lipid membranes, Caco-2 cell monolayers and rat jejunum.
Berginc K; Zakelj S; Levstik L; Ursic D; Kristl A
Eur J Pharm Biopharm; 2007 May; 66(2):281-5. PubMed ID: 17129714
[TBL] [Abstract][Full Text] [Related]
38. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).
Smetanova L; Stetinova V; Kholova D; Kvetina J; Smetana J; Svoboda Z
Neuro Endocrinol Lett; 2009; 30 Suppl 1():101-5. PubMed ID: 20027153
[TBL] [Abstract][Full Text] [Related]
39. Prediction of the skin permeability of topical drugs using in silico and in vitro models.
Alonso C; Carrer V; Espinosa S; Zanuy M; Córdoba M; Vidal B; Domínguez M; Godessart N; Coderch L; Pont M
Eur J Pharm Sci; 2019 Aug; 136():104945. PubMed ID: 31163216
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of a novel Caco-2 cell perfusion system. I. In vitro prediction of the absorption potential of passively diffused compounds.
Masungi C; Borremans C; Willems B; Mensch J; Van Dijck A; Augustijns P; Brewster ME; Noppe M
J Pharm Sci; 2004 Oct; 93(10):2507-21. PubMed ID: 15349960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
